麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Jun 23 2025

Full Issue

A Dose Of Upbeat And Inspiring News

Today's stories are on type 1 diabetes, lupus, breast cancer, hearing aids, and more.

A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need much lower doses. The experimental treatment, called zimislecel and made by Vertex Pharmaceuticals of Boston, involves stem cells that scientists prodded to turn into pancreatic islet cells, which regulate blood glucose levels. (Kolata, 6/20)

CAR T-cell therapy, a kind of 鈥渓iving drug鈥 that modifies patients鈥 immune cells to help them attack misbehaving ones, has been used with significant success to treat some cancers, particularly of the blood. A growing body of evidence has suggested that the therapy can also treat a severe form of lupus that, at best, can be managed as a lifelong condition and, at worst, resists treatment and can lead to organ failure and death. (Agrawal, 6/18)

A venomous creature from the Amazon rainforest may hold the key to fighting one of the deadliest cancers affecting women today. (Notarantonio, 6/18)

Sue Baker was told that she had two options after her heart started to fail after years of intervention: Enter palliative care, or try an experimental surgery. (Breen, 6/21)

In the first half of 2025, eight systems have performed first-of-their-kind procedures and clinical treatments. (Taylor, 6/16)

Also 鈥

Village Hearth in Durham, North Carolina, a retirement village for people 55 and older who identify as LGBTQ+, is one of the nation's first co-housing developments created specifically for an aging, queer population. (Samlian and Hastey, 6/19)

These aren鈥檛 just any specs. They鈥檙e eyeglasses with hearing aids built in, designed for people with mild to moderate hearing loss. Look closely and you鈥檒l see tiny speakers in the arms and microphones around the front. The $1,200 Nuance Audio frames, which launched in the U.S. in April, join Apple鈥檚聽AirPods Pro 2 as an auditory option for people who don鈥檛 want traditional hearing aids. (Nguyen, 6/22)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优